379 related articles for article (PubMed ID: 25701504)
1. Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells.
Park JH; Yoon J
Int Immunopharmacol; 2015 Apr; 25(2):276-84. PubMed ID: 25701504
[TBL] [Abstract][Full Text] [Related]
2. Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
Zhuang W; Li Z; Dong X; Zhao N; Liu Y; Wang C; Chen J
Exp Lung Res; 2019; 45(5-6):157-166. PubMed ID: 31268360
[No Abstract] [Full Text] [Related]
3. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
4. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.
Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G
World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways.
Zhou XL; Xu P; Chen HH; Zhao Y; Shen J; Jiang C; Jiang S; Ni SZ; Xu B; Li L
Sci Rep; 2017 Nov; 7(1):14727. PubMed ID: 29116196
[TBL] [Abstract][Full Text] [Related]
6. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
7. [Effect of schisandrin B on lung mRNA expression of transforming growth factor-beta1 signal transduction molecule in rat lungs exposed to silica].
Fan LH; Liu TF; Guo M; Liu ML; Wang ZP; Si SJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Apr; 29(4):255-9. PubMed ID: 21941776
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
9. Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial-mesenchymal transition.
Lee WR; Kim KH; An HJ; Kim JY; Lee SJ; Han SM; Pak SC; Park KK
Biochem Biophys Res Commun; 2014 Jul; 450(1):195-201. PubMed ID: 24878534
[TBL] [Abstract][Full Text] [Related]
10. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract][Full Text] [Related]
11. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
13. Involvement of eIF2α in halofuginone-driven inhibition of TGF-β1-induced EMT.
Duan M; Wei X; Cheng Z; Liu D; Fotina H; Xia X; Hu J
J Biosci; 2020; 45():. PubMed ID: 32457283
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-Converting Enzyme 2 Inhibits Lipopolysaccharide-Caused Lung Fibrosis via Downregulating the Transforming Growth Factor
Lin X; Lin W; Zhuang Y; Gao F
J Pharmacol Exp Ther; 2022 Jun; 381(3):236-246. PubMed ID: 35347063
[TBL] [Abstract][Full Text] [Related]
15. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
[TBL] [Abstract][Full Text] [Related]
16. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells.
Kolosova I; Nethery D; Kern JA
J Cell Physiol; 2011 May; 226(5):1248-54. PubMed ID: 20945383
[TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.
Velden JL; Alcorn JF; Guala AS; Badura EC; Janssen-Heininger YM
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):571-81. PubMed ID: 20581097
[TBL] [Abstract][Full Text] [Related]
18. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
19. The effect of sesamin on airway fibrosis in vitro and in vivo.
Lin CH; Shen ML; Kao ST; Wu DC
Int Immunopharmacol; 2014 Sep; 22(1):141-50. PubMed ID: 24978608
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]